<div class="container">

<table style="width: 100%;"><tr>
<td>aids</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>AIDS drug trial data</h2>

<h3>Description</h3>

<p>This dataset describes a randomized clinical trial (Goldman et 
al., 1996) in which both survival and longitudinal data were collected to 
compare the efficacy and safety of two antiretroviral drugs, namely ddI 
(didanosine) and ddC (zalcitabine), in treating HIV-infected patients 
intolerant or failing zidovudine (AZT) therapy.
</p>


<h3>Usage</h3>

<pre><code class="language-R">data(aids)
</code></pre>


<h3>Format</h3>

<p>A <code>data.frame</code> in the unbalanced format with 1405 longitudinal 
observations from 467 subjects. The columns are:
</p>

<dl>
<dt><code>id</code></dt>
<dd>
<p>integer: number for patient identification.</p>
</dd>
<dt><code>time</code></dt>
<dd>
<p>numeric: time to death (or censoring).</p>
</dd>
<dt><code>death</code></dt>
<dd>
<p>integer: event indicator. Coded as <code>0 = 
  </code>right-censoring, and <code>1 = </code>death.</p>
</dd>
<dt><code>obstime</code></dt>
<dd>
<p>numeric: measurement times for the repeated CD4 count
measurements.</p>
</dd>
<dt><code>CD4</code></dt>
<dd>
<p>numeric: CD4 cell counts measured at <code>obstime</code>.</p>
</dd>
<dt><code>drug</code></dt>
<dd>
<p>factor: drug indicator. Coded as <code>ddI = </code>didanosine
and <code>ddC = </code>zalcitabine.</p>
</dd>
<dt><code>gender</code></dt>
<dd>
<p>factor: gender indicator. Coded as <code>male</code> and 
<code>female</code>.</p>
</dd>
<dt><code>prevOI</code></dt>
<dd>
<p>factor: opportunistic infection indicator. Coded as 
<code>AIDS = </code>AIDS diagnosis at study entry, and <code>noAIDS = </code>no 
previous infection.</p>
</dd>
<dt><code>AZT</code></dt>
<dd>
<p>factor: AZT intolerance/failure indicator. Coded as 
<code>intolerance</code> or <code>failure</code>.</p>
</dd> 
</dl>
<h3>Source</h3>

<p>Guo X, Carlin B. Separate and joint modeling of longitudinal and
event time data using standard computer packages. 
<em>The American Statistician</em>. 2004; <strong>58</strong>: 16-24
</p>


<h3>References</h3>

<p>Goldman A, Carlin B, Crane L, Launer C, Korvick J, Deyton L, Abrams D.
Response of CD4 and clinical consequences to treatment using ddI or ddC in
patients with advanced HIV infection. <em>Journal of Acquired Immune
Deficiency Syndromes and Human Retrovirology</em>. 1996; <strong>11</strong>: 161-169
URL: <a href="http://www.biostat.umn.edu/~brad/data.html">http://www.biostat.umn.edu/~brad/data.html</a>.
</p>


<h3>See Also</h3>

<p><code>heart.valve</code>, <code>epileptic</code>, 
<code>mental</code>, <code>liver</code>.
</p>


</div>